| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $0 | +812 | +4.28% | $0.00 | 19.8 K | Jun 1, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -812 | -100% | $0.00 | 0 | Jun 1, 2022 | Common Stock | 812 | $0.00 | Direct | F1 |
| transaction | CNMD | Options To Purchase Common Stock | Award | $0 | +3.45 K | $0.00 | 3.45 K | Jun 1, 2022 | Common Stock | 3.45 K | $111.79 | Direct | F2 | |
| transaction | CNMD | Rsus (restricted Stock Units) | Award | $0 | +335 | $0.00 | 335 | Jun 1, 2022 | Common Stock | 335 | $0.00 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
| F2 | The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |